The effects of RKIP gene expression on the biological characteristics of human triple-negative breast cancer cells in vitro

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Tumor Biology

• Publication date

  2012-02-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s13277-012-0358-7PMID 22373584
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• GRB7 is required for triple-negative breast cancer cell invasion and survival

  2012cited by this paper
• The Role of Raf Kinase Inhibitor Protein in Rheumatoid Fibroblast-like Synoviocytes Invasiveness and Cytokine and Matrix Metalloproteinase Expression

  2011cited by this paper
• Role of Raf Kinase Inhibitor Protein in Pathophysiology of Prostate Cancer.

  2011cited by this paper
• RB1 and p53 at the crossroad of EMT and triple-negative breast cancer

  2011cited by this paper
• Signalling pathway for RKIP and Let‐7 regulates and predicts metastatic breast cancer

  2011cited by this paper
• The novel role of Yin Yang 1 in the regulation of epithelial to mesenchymal transition in cancer via the dysregulated NF-κB/Snail/YY1/RKIP/PTEN Circuitry.

  2011cited by this paper
• Differential Impact of EGFR-Targeted Therapies on Hypoxia Responses: Implications for Treatment Sensitivity in Triple-Negative Metastatic Breast Cancer

  2011cited by this paper
• Antitumor Activity of Noscapine in Combination with Doxorubicin in Triple Negative Breast Cancer

  2011cited by this paper
• Dual role of NO donors in the reversal of tumor cell resistance and EMT: Downregulation of the NF-κB/Snail/YY1/RKIP circuitry.

  2011cited by this paper
• The role of survivin in diagnosis, prognosis and treatment of breast cancer.

  2011cited by this paper
• Raf kinase inhibitor protein suppresses nuclear factor-κB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression.

  2010cited by this paper
• PEBP1 downregulation is associated to poor prognosis in HCC related to hepatitis B infection.

  2010cited by this paper
• Treatment options for patients with triple-negative breast cancer

  2010cited by this paper
• Neoadjuvant therapy for locally advanced breast cancer: Focus on chemotherapy and biological targeted treatments' armamentarium.

  2010cited by this paper
• The Role of B-RAF Mutations in Melanoma and the Induction of EMT via Dysregulation of the NF-κB/Snail/RKIP/PTEN Circuit.

  2010cited by this paper
• Headway in resistance to endocrine therapy in breast cancer.

  2010cited by this paper
• Effects of Raf Kinase Inhibitor Protein Expression on Metastasis and Progression of Human Breast Cancer

  2009cited by this paper
• Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer.

  2009cited by this paper
• Raf kinase inhibitory protein (RKIP): A physiological regulator and future therapeutic target

  2008cited by this paper
• Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor

  2008cited by this paper
• Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability

  2008cited by this paper
• Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype

  2007cited by this paper
• The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling.

  2007cited by this paper
• Prognostic markers in triple‐negative breast cancer

  2007cited by this paper
• Hyperactive Ras in developmental disorders and cancer

  2007cited by this paper
• MAP kinase meets mitosis: A role for Raf Kinase Inhibitory Protein in spindle checkpoint regulation

  2007cited by this paper
• Triple-negative breast cancer: therapeutic options.

  2007cited by this paper
• Growth-suppressive function of phosphatidylethanolamine-binding protein in anaplastic thyroid cancer.

  2006cited by this paper
• Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells.

  2006cited by this paper
• Reduction of Raf-1 Kinase Inhibitor Protein Expression Correlates with Breast Cancer Metastasis

  2005cited by this paper
• Metastasis suppressor genes: a role for raf kinase inhibitor protein (RKIP).

  2004cited by this paper
• Raf kinase inhibitory protein inhibits β-cell proliferation

  2004cited by this paper
• Raf kinase inhibitory protein inhibits beta-cell proliferation.

  2004cited by this paper
• Repeated observation of breast tumor subtypes in independent gene expression data sets

  2003cited by this paper
• Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis.

  2003cited by this paper
• Behaviour of bovine phosphatidylethanolamine-binding protein with model membranes. Evidence of affinity for negatively charged membranes.

  2001cited by this paper
• Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions.

  2001cited by this paper
• Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP

  1999cited by this paper

• Pan-Cancer Computational Analysis of RKIP (PEBP1) and LKB1 (STK11) Co-Expression Highlights Distinct Immunometabolic Dynamics and Therapeutic Responses Within the Tumor Microenvironment

  2025cites this paper
• Opposing roles of YY1 and RKIP in cancer progression and therapy resistance.

  2025cites this paper
• A Stochastic Binary Model for the Regulation of Gene Expression to Investigate Responses to Gene Therapy

  2022cites this paper
• Regulation on tumor metastasis by Raf kinase inhibitory protein: New insight with reactive oxygen species signaling

  2021cites this paper
• YY1 is involved in the pathogenesis and malignant properties of human triple-negative breast cancer (TNBC)

  2021cites this paper
• Role of RKIP in the tumor response to photooxidative damage

  2020cites this paper
• Alter between gut bacteria and blood metabolites and the anti-tumor effects of Faecalibacterium prausnitzii in breast cancer

  2020cites this paper
• RKIP a master of regulatory pathways: Perspectives

  2020cites this paper
• A New Linkage between the Tumor Suppressor RKIP and Autophagy: Targeted Therapeutics.

  2018cites this paper
• RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and Impact

  2018cites this paper
• Role of RKIP in human hepatic stellate cell proliferation, invasion, and metastasis

  2018cites this paper
• Understanding perspectives of signalling mechanisms regulating PEBP1 function

  2016cites this paper
• The biological complexity of RKIP signaling in human cancers

  2015cites this paper
• Epigenetic changes and nuclear factor-κB activation, but not microRNA-224, downregulate Raf-1 kinase inhibitor protein in triple-negative breast cancer SUM 159 cells.

  2015cites this paper
• Expression of RKIP in chronic myelogenous leukemia K562 cell and inhibits cell proliferation by regulating the ERK/MAPK pathway

  2014cites this paper
• Original Article Clinical implications for loss or diminution of expression of Raf-1 kinase inhibitory protein and its phosphorylated form in ductal breast cancer

  2013cites this paper
• Clinical implications for loss or diminution of expression of Raf-1 kinase inhibitory protein and its phosphorylated form in ductal breast cancer.

  2013cites this paper
• Gemifloxacin inhibits migration and invasion and induces mesenchymal–epithelial transition in human breast adenocarcinoma cells

  2013cites this paper
• Low RKIP expression associates with poor prognosis in bladder cancer patients

  2013cites this paper